Steven Cohen's PLRX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 20,073 shares of Pliant Therapeutics, Inc. (PLRX) worth $22,883, representing 0.00% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in PLRX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 4.34 M shares. Largest reduction occurred in Q4 2025, reducing 4.29 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Pliant Therapeutics (PLRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pliant Therapeutics (PLRX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -26,981 | Reduce 57.34% | 20,073 | $1.14 |
| Q1 2026 | +517 | Add 1.11% | 47,054 | $1.26 |
| Q4 2025 | -4.29 M | Reduce 98.93% | 46,537 | $1.22 |
| Q3 2025 | +4.34 M | New Buy | 4.34 M | $1.48 |
| Q2 2023 | -9,697 | Sold Out | 0 | $0.00 |
| Q1 2023 | +9,697 | New Buy | 9,697 | $26.60 |
| Q3 2022 | -484,524 | Sold Out | 0 | $0.00 |
| Q2 2022 | -285,476 | Reduce 37.07% | 484,524 | $8.01 |
| Q1 2022 | -365,100 | Reduce 32.16% | 770,000 | $7.01 |
| Q4 2021 | +1.14 M | New Buy | 1.14 M | $13.50 |
| Q4 2020 | -51,500 | Sold Out | 0 | $0.00 |
| Q3 2020 | +51,500 | New Buy | 51,500 | $22.64 |
Steven Cohen's Pliant Therapeutics Investment FAQs
Steven Cohen first purchased Pliant Therapeutics, Inc. (PLRX) in Q3 2020, acquiring 51,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Pliant Therapeutics, Inc. (PLRX) for 12 quarters since Q3 2020.
Steven Cohen's largest addition to Pliant Therapeutics, Inc. (PLRX) was in Q3 2025, adding 4,338,394 shares worth $6.42 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 20,073 shares of Pliant Therapeutics, Inc. (PLRX), valued at approximately $22,883.
As of the Q2 2026 filing, Pliant Therapeutics, Inc. (PLRX) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Pliant Therapeutics, Inc. (PLRX) was 4,338,394 shares, as reported at the end of Q3 2025.